Free fatty acid-induced histone acetyltransferase activity accelerates lipid accumulation in HepG2 cells
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
BACKGROUND/OBJECTIVES: Non-alcoholic fatty liver disease (NAFLD) is a common metabolic disease triggered by epigenetic alterations, including lysine acetylation at histone or non-histone proteins, affecting the stability or transcription of lipogenic genes. Although various natural dietary compounds have anti-lipogenic effects, their effects on the acetylation status and lipid metabolism in the liver have not been thoroughly investigated. MATERIALS/METHODS: Following oleic-palmitic acid (OPA)-induced lipid accumulation in HepG2 cells, the acetylation status of histone and non-histone proteins, HAT activity, and mRNA expression of representative lipogenic genes, including PPARγ, SREBP-1c, ACLY, and FASN, were evaluated. Furthermore, correlations between lipid accumulation and HAT activity for 22 representative natural food extracts (NExs) were evaluated. RESULTS: Non-histone protein acetylation increased following OPA treatment and the acetylation of histones H3K9, H4K8, and H4K16 was accelerated, accompanied by an increase in HAT activity. OPA-induced increases in the mRNA expression of lipogenic genes were down-regulated by C-646, a p300/CBP-specific inhibitor. Finally, we detected a positive correlation between HAT activity and lipid accumulation (Pearson’s correlation coefficient = 0.604) using 22 NExs. CONCLUSIONS: Our results suggest that NExs have novel applications as nutraceutical agents with HAT inhibitor activity for the prevention and treatment of NAFLD.
Abstract
BACKGROUND/OBJECTIVES: Non-alcoholic fatty liver disease (NAFLD) is a common metabolic disease triggered by epigenetic alterations, including lysine acetylation at histone or non-histone proteins, affecting the stability or transcription of lipogenic genes. Although various natural dietary compounds have anti-lipogenic effects, their effects on the acetylation status and lipid metabolism in the liver have not been thoroughly investigated. MATERIALS/METHODS: Following oleic-palmitic acid (OPA)-induced lipid accumulation in HepG2 cells, the acetylation status of histone and non-histone proteins, HAT activity, and mRNA expression of representative lipogenic genes, including PPARγ, SREBP-1c, ACLY, and FASN, were evaluated. Furthermore, correlations between lipid accumulation and HAT activity for 22 representative natural food extracts (NExs) were evaluated. RESULTS: Non-histone protein acetylation increased following OPA treatment and the acetylation of histones H3K9, H4K8, and H4K16 was accelerated, accompanied by an increase in HAT activity. OPA-induced increases in the mRNA expression of lipogenic genes were down-regulated by C-646, a p300/CBP-specific inhibitor. Finally, we detected a positive correlation between HAT activity and lipid accumulation (Pearson’s correlation coefficient = 0.604) using 22 NExs. CONCLUSIONS: Our results suggest that NExs have novel applications as nutraceutical agents with HAT inhibitor activity for the prevention and treatment of NAFLD.
참고문헌 (40)
- Ahmed MH, "Nonalcoholic Fatty liver disease and risk of diabetes and cardiovascular disease: what is important for primary care physicians?", J Family Med Prim Care, 4, pp.45~52 (2015)
- Sun C, "Potential epigenetic mechanism in non-alcoholic fatty liver disease", Int J Mol Sci, 16, pp.5161~5179 (2015)
- Wang Q, "Protein lysine acetylated", deacetylated enzymes and the metabolism-related diseases, 2016, pp.7, 454~467
- Castaño-Cerezo S, "Protein acetylation affects acetate metabolism, motility and acid stress response in Escherichia coli", Mol Syst Biol, 10, pp.762~ (2014)
- van Noort V, "Cross-talk between phosphorylation and lysine acetylation in a genome-reduced bacterium", Mol Syst Biol, 8, pp.571~ (2012)
- 유병조, "The Diversity of Lysine-Acetylated Proteins in Escherichia coli", Journal of Microbiology and Biotechnology, 18(9), pp.1529~1536 (2008), 한국미생물·생명공학회
- Kim D, "The acetylproteome of Gram-positive model bacterium Bacillus subtilis", Proteomics, 13, pp.1726~1736 (2013)
- Fukushima A, "Acetylation control of cardiac fatty acid β-oxidation and energy metabolism in obesity, diabetes, and heart failure", Biochim Biophys Acta, 1862, pp.2211~2220 (2016)
- Simon Schenk, "Is Acetylation a Metabolic Rheostat that Regulates Skeletal Muscle Insulin Action?", Molecules and Cells, 38(4), pp.297~303 (2015), 한국분자세포생물학회
- Clayton AL, "Enhanced histone acetylation and transcription: a dynamic perspective", Mol Cell, 23, pp.289~296 (2006)
- Yang XJ, "The Rpd3", Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men, 2008, pp.9, 206~218
- Haberland M, "The many roles of histone deacetylases in development and physiology: implications for disease and therapy", Nat Rev Genet, 10, pp.32~42 (2009)
- Zhao S, "Regulation of cellular metabolism by protein lysine acetylation", Science, 327, pp.1000~1004 (2010)
- Wang Q, "Acetylation of metabolic enzymes coordinates carbon source utilization and metabolic flux", Science, 327, pp.1004~1007 (2010)
- Podrini C, "Redox homeostasis and epigenetics in non-alcoholic fatty liver disease (NAFLD)", Curr Pharm Des, 19, pp.2737~2746 (2013)
- Xu X, "Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP", Semin Liver Dis, 33, pp.301~311 (2013)
- Bricambert J, "Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice", J Clin Invest, 120, pp.4316~4331 (2010)
- Shankar E, "Dietary phytochemicals as epigenetic modifiers in cancer: promise and challenges", Semin Cancer Biol, 40-41, pp.82~99 (2016)
- Chalasani N, "Genomewide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease", Gastroenterology, 139, pp.1567~1576.e6 (2010)
- 황진택, "Ethanol extract of Allium fistulosum inhibits development of non-alcoholic fatty liver disease", Nutrition Research and Practice, 12(2), pp.110~117 (2018), 한국영양학회
- Choi KC, "Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation", Cancer Res, 69, pp.583~592 (2009)
- Pan MH, "Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds", Mol Nutr Food Res, 58, pp.147~171 (2014)
- Pirola CJ, "Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease", Gut, 62, pp.1356~1363 (2013)
- Anstee QM, "The genetics of NAFLD", Nat Rev Gastroenterol Hepatol, 10, pp.645~655 (2013)
- Afonso MB, "Circulating microRNAs as potential biomarkers in non-alcoholic fatty liver disease and hepatocellular carcinoma", J Clin Med, 5, pp.30~ (2016)
- Granger A, "Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice", FASEB J, 22, pp.3549~3560 (2008)
- Tian Y, "Epigenetic regulation of hepatocellular carcinoma in non-alcoholic fatty liver disease", Semin Cancer Biol, 23, pp.471~482 (2013)
- Lo KA, "Genome-wide profiling of H3K56 acetylation and transcription factor binding sites in human adipocytes", PLoS One, 6, pp.e19778~ (2011)
- Mikula M, "Obesity increases histone H3 lysine 9 and 18 acetylation at Tnfa and Ccl2 genes in mouse liver", Int J Mol Med, 34, pp.1647~1654 (2014)
- Alrob OA, "Obesity-induced lysine acetylation increases cardiac fatty acid oxidation and impairs insulin signalling", Cardiovasc Res, 103, pp.485~497 (2014)
- Ponugoti B, "SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism", J Biol Chem, 285, pp.33959~33970 (2010)
- Sterner DE, "Acetylation of histones and transcriptionrelated factors", Microbiol Mol Biol Rev, 64, pp.435~459 (2000)
- Verdone L, "Histone acetylation in gene regulation", Brief Funct Genomics Proteomics, 5, pp.209~221 (2006)
- Kurdistani SK, "Histone acetylation and deacetylation in yeast", Nat Rev Mol Cell Biol, 4, pp.276~284 (2003)
- Fajas L, "Regulation of peroxisome proliferator-activated receptor gamma expression by adipocyte differentiation and determination factor 1", sterol regulatory element binding protein 1: implications for adipocyte differentiation and metabolism, 1999, pp.19, 5495~5503
- Pettinelli P, "Up-regulation of PPAR-gamma mRNA expression in the liver of obese patients: an additional reinforcing lipogenic mechanism to SREBP-1c induction", J Clin Endocrinol Metab, 96, pp.1424~1430 (2011)
- Tolman KG, "Treatment of non-alcoholic fatty liver disease", Ther Clin Risk Manag, 3, pp.1153~1163 (2007)
- Rodgers RJ, "Anti-obesity drugs: past, present and future", Dis Model Mech, 5, pp.621~626 (2012)
- Ann JY, "Mulberry leaves (Morus alba L.) ameliorate obesity-induced hepatic lipogenesis, fibrosis, and oxidative stress in high-fat diet-fed mice", Genes Nutr, 10, pp.46~ (2015)
- Sun JH, "Metabolomics study of the therapeutic mechanism of Schisandra Chinensis lignans in diet-induced hyperlipidemia mice", Lipids Health Dis, 16, pp.145~ (2017)
